Kadimastem Finishes Treating Second Group of ALS Patients with AstroRx in Phase 1/2a Trial
News
Kadimastem has finished treating its second group of participants in a Phase 1/2a clinical trial testing the safety and preliminary efficacy of AstroRx, an investigational stem cell therapy for amyotrophic ... Read more